DOCUSIGN, INC.·4

Mar 3, 6:12 PM ET

Marrs Anna 4

4 · DOCUSIGN, INC. · Filed Mar 3, 2026

Research Summary

AI-generated summary of this filing

Updated

DocuSign (DOCU) Director Anna Marrs Sells 365 Shares

What Happened
Anna Marrs, a director at DocuSign (DOCU), had 729 restricted stock units (RSUs) converted to shares (reported as an exercise/conversion of a derivative at $0.00) on 2026-02-28. The filing also reports an open-market sale of 365 shares on 2026-03-03 at $45.02 per share for total proceeds of $16,432. The transactions show a net sale of 365 shares; the RSU conversion and the zero-price derivative disposition are reported separately in the Form 4.

Key Details

  • Dates and prices:
    • 2026-02-28: 729 RSUs converted to 729 shares (reported as M, acquired at $0.00).
    • 2026-02-28: 729 shares reported disposed as a derivative at $0.00 (same date).
    • 2026-03-03: 365 shares sold on the open market at $45.02, proceeds $16,432.
  • Net effect: 365-share reduction in holdings (729 conversion netted by a same-day derivative disposition; then 365 shares sold). The Form 4 does not state the total number of shares owned after these transactions.
  • Notable footnotes:
    • F1: The sale was effected pursuant to a Rule 10b5-1 trading plan.
    • F2–F4: The transactions involve RSUs (each RSU = one share) with a vesting schedule beginning May 29, 2025 and vesting quarterly over one year; RSUs do not expire.
  • Filing timeliness: The form was filed 2026-03-03 covering transactions dated 2026-02-28 and 2026-03-03. The filing does not indicate it was late.

Context

  • These entries reflect RSU conversion and a subsequent open-market sale under a prearranged 10b5-1 plan. The zero-dollar derivative entries reflect conversion/handling of RSUs as reported; the Form 4 treats those as exercise/conversion and a derivative disposition. The sale is relatively small ($16.4k) and routine; factual reporting here does not indicate the insider’s motivations.

Insider Transaction Report

Form 4
Period: 2026-02-28
Marrs Anna
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-28+72912,254 total
  • Sale

    Common Stock

    [F1]
    2026-03-03$45.02/sh365$16,43211,889 total
  • Exercise/Conversion

    Restricted Stock Units

    [F2][F3][F4]
    2026-02-28729729 total
    Common Stock (729 underlying)
Footnotes (4)
  • [F1]The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
  • [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
  • [F3]The RSUs have a vest commencement date of May 29, 2025 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date.
  • [F4]The RSUs do not expire; they either vest or are canceled prior to vesting date.
Signature
/s/ Derrick Chapman, Attorney-in-fact|2026-03-03

Documents

1 file
  • 4
    wk-form4_1772579554.xmlPrimary

    FORM 4